The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
High throughput solubility measurement in drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Studien über die Bildung und Umwandlung fester Körper: 1. Abhandlung: Übersättigung und Überkaltung
Ostwald, W. (1897) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-1897-2233 · Cited by 2,103
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
Galia, E., Nicolaides, E., Hörter, D., Löbenberg, R., Reppas, C., & Dressman, J. B. (1998) · Pharmaceutical Research · doi:10.1023/a:1011910801212 · Cited by 927
Lindenberg, M., Kopp, S., & Dressman, J. B. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.001 · Cited by 864
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
Dokoumetzidis, A., & Macheras, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.011 · Cited by 715
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) · Organic Process Research & Development · doi:10.1021/op000023y · Cited by 687
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Trends in Solubility of Polymorphs
Pudipeddi, M., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20302 · Cited by 505
High-throughput and ultra-high-throughput screening: solution- and cell-based approaches
Sundberg, S. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00051-8 · Cited by 455
Bevan, C. D., & Lloyd, R. S. (2000) · Analytical Chemistry · doi:10.1021/ac9912247 · Cited by 345
High throughput physicochemical profiling for drug discovery
Kerns, E. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1134 · Cited by 343
Hert, J., Willett, P., Wilton, D. J., Acklin, P., Azzaoui, K., Jacoby, E., & Schuffenhauer, A. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034231b · Cited by 310
Estimation of the increase in solubility of drugs as a function of bile salt concentration
Mithani, S. D., Bakatselou, V., TenHoor, C. N., & Dressman, J. B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016062224568 · Cited by 303
The rise and rise of drug delivery
Rosen, H., & Abribat, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1721 · Cited by 296
Glomme, A., März, J., & Dressman, J. B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20212 · Cited by 295
Yazdanian, M., Briggs, K., Jankovsky, C., & Hawi, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016242.48642.71 · Cited by 290
Pharmaceutical profiling in drug discovery
Kerns, E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02649-7 · Cited by 288
Drugs as materials: valuing physical form in drug discovery
Gardner, C. R., Walsh, C. T., & Almarsson, Ö. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1550 · Cited by 284
Avdeef, A., Berger, C. M., & Brownell, C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007526826979 · Cited by 260
Cheng, A., & Merz, K. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020266b · Cited by 236
Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds
Dressman, J. B., Amidon, G. L., & Fleisher, D. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740523 · Cited by 221
Lennernäs, H., & Abrahamsson, B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055263 · Cited by 215
Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 208
Accuracy of calculated pH-dependent aqueous drug solubility
Bergström, C. A. S., Luthman, K., & Artursson, P. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.006 · Cited by 197
Current trends in lead discovery: Are we looking for the appropriate properties?
Oprea, T. I. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020877402759 · Cited by 193
Predicting aqueous solubility from structure
Delaney, J. S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03365-3 · Cited by 191
Balakin, K., Savchuk, N., & Tetko, I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706775197917 · Cited by 183
Biological assay challenges from compound solubility: strategies for bioassay optimization
Di, L., & Kerns, E. H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.004 · Cited by 181
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
Parrott, N., & Lavé, T. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00132-x · Cited by 170
Examination of the Solubilization of Drugs by Bile Salt Micelles
Wiedmann, T. S., & Kamel, L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10158 · Cited by 169
Avdeef, A., & Testa, B. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012496 · Cited by 151
A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids
Pedersen, B. L., Müllertz, A., BRØNDSTED, H. V., & Kristensen, H. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007576713216 · Cited by 141
Pharmaceutical evaluation of early development candidates “the 100 mg-approach”
Balbach, S., & Korn, C. B. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.034 · Cited by 139
Polli, J. E., Yu, L. X., Cook, J., Amidon, G. L., Borchardt, R. T., Burnside, B. A., Burton, P. S., Chen, M., Conner, D. P., Faustino, P. J., et al. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20064 · Cited by 123
Sun, D., Yu, L. X., Hussain, M. A., Wall, D. A., Smith, R. L., & Amidon, G. L. (2004) · PubMed · Cited by 119
Varma, M., Khandavilli, S., Ashokraj, Y., Jain, A., Dhanikula, A., Sood, A., Thomas, N., Pillai, O., Sharma, P., Gandhi, R., et al. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335423 · Cited by 107
Box, K. J., Völgyi, G., Baka, E., Stuart, M., Takács‐Novák, K., & Comer, J. E. A. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20613 · Cited by 104
(2004) · Cited by 101
Physicochemical profiling: overview of the screens
Kerns, E. H., & Di, L. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.08.011 · Cited by 99
Self Association and Cyclodextrin Solubilization of NSAIDs
Magnusdottir, A., Másson, M., & Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023079322024 · Cited by 99
The BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Fourier Transform Infrared Imaging for High-Throughput Analysis of Pharmaceutical Formulations
Chan, K. L. A., & Kazarian, S. G. (2005) · Journal of Combinatorial Chemistry · doi:10.1021/cc049840q · Cited by 78
Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs
Li, P., Zhao, L., & Yalkowsky, S. H. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990159d · Cited by 78
Taub, M. E., Kristensen, L. L., & Frøkjær, S. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00015-5 · Cited by 77
Chen, T., Shen, H., & Zhu, C. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023330075 · Cited by 77
Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples
Rinaki, E., Dokoumetzidis, A., Valsami, G. N., & Macheras, P. E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041450.25106.c8 · Cited by 76
High throughput solubility measurement with automated polarized light microscopy analysis
Sugano, K., Kato, T., Suzuki, K., Keiko, K., Sujaku, T., & Mano, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20628 · Cited by 71
Mensch, J., Noppe, M., Adriaensen, J., Melis, A., Mackie, C. E., Augustijns, P., & Brewster, M. E. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.031 · Cited by 71
Characterization of Prototype Self-Nanoemulsifying Formulations of Lipophilic Compounds
Nielsen, F. S., Gibault, E., Ljusberg‐Wahren, H., Arleth, L., Pedersen, J. S., & Müllertz, A. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20673 · Cited by 67
Development of a partially automated solubility screening (PASS) assay for early drug development
Alsenz, J., Meister, E., & Haenel, E. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20814 · Cited by 62
Self-citationPAMPA–Excipient Classification Gradient Map
Bendels, S., Tsinman, O., Wagner, B., Lipp, D., Parrilla, I., Kansy, M., & Avdeef, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9137-8 · Cited by 57
Self-citationAlvarez‐Núñez, F., & Yalkowsky, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00386-0 · Cited by 56
Biopharmaceutics Classification by High Throughput Solubility Assay and PAMPA
Obata, K., Sugano, K., Machida, M., & Aso, Y. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028713 · Cited by 53
Determination of the Aqueous Solubility of Drugs Using a Convenient 96-Well Plate-Based Assay
Roy, D. S., Ducher, F., Laumain, A., et al. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100000135 · Cited by 46
Analysis of the Solubilization of Steroids by Bile Salt Micelles
Cai, X., Grant, D. J. W., & Wiedmann, T. S. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9602148 · Cited by 44
Chen, H., Zhang, Z., McNulty, C., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1025021603288 · Cited by 42
Assessment of Similarity Factor Using Different Weighting Approaches
Gohel, M. C., Sarvaiya, K. G., Mehta, N. R., Soni, C., Vyas, V. U., & Dave, R. K. (2005) · Dissolution Technologies · doi:10.14227/dt120405p22 · Cited by 41
Automation in Pharmaceutical Profiling
Kerns, E. H., & Di, L. (2005) · JALA Journal of the Association for Laboratory Automation · doi:10.1016/j.jala.2004.11.002 · Cited by 38
Computational models to predict aqueous drug solubility, permeability and intestinal absorption
Bergström, C. A. S. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.613 · Cited by 37
Mansky, P. A., Dai, W., Li, S., Pollock‐Dove, C., Daehne, K., Dong, L., & Eichenbaum, G. M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20799 · Cited by 36
High-Throughput Physicochemical and In Vitro ADMET Screening: A Role in Pharmaceutical Profiling
Valko, K. L., & Reynolds, D. P. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503020-00002 · Cited by 23
Rapid, small-scale determination of organic solvent solubility using a thermogravimetric analyzer
Greene, L. R., Blackburn, A. C., & Miller, J. M. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.03.022 · Cited by 17
A hierarchical screening methodology for physicochemical/ADME/Tox profiling
DeWitte, R. S., & Robins, R. H. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.5.805 · Cited by 8
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Wischke, C., & Schwendeman, S. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.042 · Cited by 790
Handbook of Solubility Data for Pharmaceuticals
Jouyban, A. (2009) · CRC Press eBooks · doi:10.1201/9781439804889 · Cited by 718
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
Metadata
- Authors
- Alsenz, J., & Kansy, M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 59
- Issue
- 7
- Pages
- 546-567
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2090234567
- Cited by
- 412
- References
- 73
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.